Logo

HP

Precision Medicine Informatics Startup Jungla Emerges From Stealth Mode
Premium

Silicon Valley Startup Jungla has a 10-year vision of its founders to improve large-scale correlation of mutations and disease.

Australian System Retains Rank as Top Life Science Computer in Latest Top500 List
Premium

Australia's Victorian Life Sciences Computation Initiative hosts the fastest life science supercomputer in the world, according to the most recent version of the Top500 list released earlier this month.

Japan Contributes Two New Life Science Systems to Latest Version of Top500 Supercomputer List
Premium

Two supercomputers dedicated to life science research — both from Japan — have joined the ranks of the world's fastest supercomputers, according to the twice-yearly Top500 list released earlier this month.

One New Life Science Machine Joins Top500 Supercomputer List as Two are Dropped
Premium

By Bernadette Toner

Two Life Science Systems Dropped from Latest Top500 Supercomputer Ranking
Premium

Supercomputers at Janelia Farm and the University of Tokyo's Laboratory for Systems Biology and Medicine did not meet the 40.1-teraflop benchmark for inclusion in the 37th edition of the twice-yearly ranking.
Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.